Quality of Life in Hodgkin Lymphoma
The long-term cure rates for Hodgkin lymphoma (HL) patients are above 80 % for all stages. Given this impressive long-term outcome for a patient population with a median age of about 30 years at diagnosis, the quality of survivorship has become more and more important. Organ dysfunctions including hypothyroidism, hypogonadism, cardiopulmonary complications, and secondary neoplasia as well as health-related quality of life (HRQoL) are major factors contributing to the patient’s general well-being.
KeywordsHodgkin Lymphoma Severe Fatigue HRQoL Assessment Hodgkin Lymphoma Patient Impaired HRQoL
- 3.U.S. Department of Health and Human Services Food and Drug Administration (2009) Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claimsGoogle Scholar
- 6.Flechtner H, Ruffer JU, Henry-Amar M et al (1998) Quality of life assessment in Hodgkin’s disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC lymphoma cooperative group. Groupe D’Etude des Lymphomes de L’Adulte and German Hodgkin Study Group. Ann Oncol 9(Suppl 5):S147–S154PubMedCrossRefGoogle Scholar
- 10.Calaminus G, Doerffel W, Baust K, Teske C, Riepenhausen M, Brämswig J, Flechtner HH, Singer S, Hinz A, Schellong G (2014) Quality of life in long-term survivors following treatment for Hodgkin’s disease during childhood and adolescence in the German multicentre studies between 1978 and 2002. Support Care Cancer 22:1519–1529PubMedCrossRefGoogle Scholar
- 21.Borchmann P, Muller H, Brillant C et al (2010) Longitudinal evaluation of quality of life and fatigue in Hodgkin lymphoma patients. ASH Ann Meet Abstr 116:935Google Scholar